While this concept contributes to the unexpected rationale of SGLT2 inhibition in the diabetic kidney, the action of SGLT2 can efficiently affect renal O2 consumption whenever cardiac or intrinsic kidney disorders result in a need to increase the glomerular filtration pressure in order to maintain the filtrate. The gene discussed is SLC5A2; the disease is kidney disorder.